United States Pharmaceuticals

Horizon Therapeutics PLC (HZNP)

Track

Ticker: HZNP Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Horizon Therapeutics PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 17 Jan 2023
Value US$2,412,814.42 | Price 92.21 | Shares 52,104 (+11.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-18 2023-01-17 PlS Planned sale
2.1
Pasternak Andy

EVP, Chief Strategy Officer

Officer
52,104 +11.1%
92.21
US$2,412,814 		52,104 +11.1% 92.21 US$2,412,814
2023-01-17 2023-01-13 PlS Planned sale
Cox Aaron

EVP, Chief Financial Officer

Officer
13,654 +42.1%
296.73
US$2,198,243 		13,654 +42.1% 296.73 US$2,198,243
2023-01-12 2023-01-11 PlS Planned sale
3.0
SHERMAN JEFFREY W

EVP and Chief Medical Officer

Officer
87,839 +10.3%
347.31
US$1,782,012 		87,839 +10.3% 347.31 US$1,782,012
2023-01-12 2023-01-10 PlS Planned sale
3.0
SHERMAN JEFFREY W

EVP and Chief Medical Officer

Officer
3,368 -7.8%
113.05
US$380,752 		3,368 -7.8% 113.05 US$380,752
2023-01-06 2023-01-06 PlS Planned sale
3.0
SHERMAN JEFFREY W

EVP and Chief Medical Officer

Officer
5,187 -9.5%
113.29
US$587,635 		5,187 -9.5% 113.29 US$587,635
2022-12-14 2022-12-13 S Sale
2.1
Pasternak Andy

EVP, Chief Strategy Officer

Officer
6,918 -16.9%
112.60
US$778,965 		6,918 -16.9% 112.60 US$778,965
2022-12-14 2022-12-13 S Sale
2.1
Pasternak Andy

EVP, Chief Strategy Officer

Officer
23,251 -36.2%
112.61
US$2,618,207 		23,251 -36.2% 112.61 US$2,618,207
2022-12-13 2022-12-12 PlS Planned sale
3.0
SHERMAN JEFFREY W

EVP and Chief Medical Officer

Officer
21,378 -20.2%
111.45
US$2,382,484 		21,378 -20.2% 111.45 US$2,382,484
2022-12-13 2022-12-12 PlS Planned sale
3.0
SHERMAN JEFFREY W

EVP and Chief Medical Officer

Officer
6,974 -11.3%
111.44
US$777,208 		6,974 -11.3% 111.44 US$777,208
2022-08-08 2022-08-04 B Purchase
2.2
Clayton Sean M.

EVP, General Counsel

Officer
745 +inf%
66.67
US$49,669 		745 +inf% 66.67 US$49,669
2022-07-29 2022-07-29 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
643 -1.9%
83.45
US$53,658 		643 -1.9% 83.45 US$53,658
2022-07-29 2022-07-29 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
4,207 -10.8%
82.44
US$346,825 		4,207 -10.8% 82.44 US$346,825
2022-07-20 2022-07-20 PlS Planned sale
Thompson Elizabeth H.Z.

EVP, Research & Development

Officer
5,917 -45.9%
85.00
US$502,945 		5,917 -45.9% 85.00 US$502,945
2022-07-20 2022-07-19 PlS Planned sale
Thompson Elizabeth H.Z.

EVP, Research & Development

Officer
82 -0.6%
85.04
US$6,973 		82 -0.6% 85.04 US$6,973
2022-07-20 2022-07-19 PlS Planned sale
Thompson Elizabeth H.Z.

EVP, Research & Development

Officer
8 -0.1%
85.02
US$680 		8 -0.1% 85.02 US$680
2022-07-11 2022-07-07 PlS Planned sale
Thompson Elizabeth H.Z.

EVP, Research & Development

Officer
82 -0.6%
85.01
US$6,971 		82 -0.6% 85.01 US$6,971
2022-06-13 2022-06-10 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
762 -1.9%
85.36
US$65,044 		762 -1.9% 85.36 US$65,044
2022-06-03 2022-06-03 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
9,800 -2.2%
92.74
US$908,852 		9,800 -2.2% 92.74 US$908,852
2022-06-03 2022-06-03 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
15,200 -3.3%
92.08
US$1,399,616 		15,200 -3.3% 92.08 US$1,399,616
2022-06-02 2022-05-31 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
2,700 -0.6%
94.46
US$255,042 		2,700 -0.6% 94.46 US$255,042
2022-06-02 2022-05-31 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
3,800 -0.9%
93.21
US$354,198 		3,800 -0.9% 93.21 US$354,198
2022-06-02 2022-05-31 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
18,500 -4.0%
92.04
US$1,702,740 		18,500 -4.0% 92.04 US$1,702,740
2022-05-20 2022-05-20 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
25,000 -5.1%
90.00
US$2,250,000 		25,000 -5.1% 90.00 US$2,250,000
2022-05-13 2022-05-11 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
17,600 -3.7%
90.00
US$1,584,000 		17,600 -3.7% 90.00 US$1,584,000
2022-05-10 2022-05-06 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
5,000 -1.1%
91.11
US$455,550 		5,000 -1.1% 91.11 US$455,550
2022-05-10 2022-05-06 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
2,400 -0.5%
90.33
US$216,792 		2,400 -0.5% 90.33 US$216,792
2022-05-04 2022-05-02 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
3,450 -0.7%
97.43
US$336,134 		3,450 -0.7% 97.43 US$336,134
2022-05-04 2022-05-02 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
7,608 -1.6%
96.62
US$735,085 		7,608 -1.6% 96.62 US$735,085
2022-05-04 2022-05-02 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
13,942 -2.9%
95.38
US$1,329,788 		13,942 -2.9% 95.38 US$1,329,788
2022-04-22 2022-04-22 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
1,087 -0.2%
109.39
US$118,907 		1,087 -0.2% 109.39 US$118,907
2022-04-22 2022-04-22 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
1,800 -0.4%
107.94
US$194,292 		1,800 -0.4% 107.94 US$194,292
2022-04-22 2022-04-22 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
5,700 -1.2%
107.02
US$610,014 		5,700 -1.2% 107.02 US$610,014
2022-04-22 2022-04-22 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
16,413 -3.2%
106.10
US$1,741,419 		16,413 -3.2% 106.10 US$1,741,419
2022-04-22 2022-04-20 PlS Planned sale
Hoelscher Paul W.

EVP, CFO

Officer
21,542 -95.4%
115.17
US$2,480,992 		21,542 -95.4% 115.17 US$2,480,992
2022-04-22 2022-04-20 PlS Planned sale
Hoelscher Paul W.

EVP, CFO

Officer
28,458 -55.7%
114.36
US$3,254,457 		28,458 -55.7% 114.36 US$3,254,457
2022-04-20 2022-04-18 PlS Planned sale
Thompson Elizabeth H.Z.

EVP, Research & Development

Officer
8,098 -38.3%
115.64
US$936,453 		8,098 -38.3% 115.64 US$936,453
2022-04-14 2022-04-12 PlS Planned sale
2.2
DesJardin Michael A.

EVP, Technical Operations

Officer
11,064 -11.8%
113.60
US$1,256,870 		11,064 -11.8% 113.60 US$1,256,870
2022-04-14 2022-04-12 PlS Planned sale
2.2
DesJardin Michael A.

EVP, Technical Operations

Officer
9,150 -8.9%
112.55
US$1,029,832 		9,150 -8.9% 112.55 US$1,029,832
2022-04-08 2022-04-08 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
16,687 -3.3%
112.72
US$1,880,959 		16,687 -3.3% 112.72 US$1,880,959
2022-04-08 2022-04-08 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
8,313 -1.6%
111.70
US$928,562 		8,313 -1.6% 111.70 US$928,562
2022-04-08 2022-04-06 PlS Planned sale
Hoelscher Paul W.

EVP, CFO

Officer
91,710 -57.9%
110.01
US$10,089,026 		91,710 -57.9% 110.01 US$10,089,026
2022-04-08 2022-04-06 PlS Planned sale
Hoelscher Paul W.

EVP, CFO

Officer
215,335 -99.5%
110.01
US$23,688,788 		215,335 -99.5% 110.01 US$23,688,788
2022-04-08 2022-04-06 PlS Planned sale
3.0
SHERMAN JEFFREY W

EVP and Chief Medical Officer

Officer
42,009 -79.8%
110.02
US$4,621,872 		42,009 -79.8% 110.02 US$4,621,872
2022-04-01 2022-03-30 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
35,480 -6.8%
105.52
US$3,743,850 		35,480 -6.8% 105.52 US$3,743,850
2022-04-01 2022-03-30 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
14,520 -2.7%
104.61
US$1,518,937 		14,520 -2.7% 104.61 US$1,518,937
2022-03-25 2022-03-25 PlS Planned sale
Hoelscher Paul W.

EVP, CFO

Officer
663 -0.4%
110.00
US$72,930 		663 -0.4% 110.00 US$72,930
2022-03-25 2022-03-25 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
25,000 -4.5%
109.37
US$2,734,340 		25,000 -4.5% 109.37 US$2,734,340
2022-03-25 2022-03-24 PlS Planned sale
Hoelscher Paul W.

EVP, CFO

Officer
1,481 -0.9%
110.00
US$162,910 		1,481 -0.9% 110.00 US$162,910
2022-03-25 2022-03-23 PlS Planned sale
Hoelscher Paul W.

EVP, CFO

Officer
11,699 -6.8%
110.01
US$1,287,018 		11,699 -6.8% 110.01 US$1,287,018
2022-03-25 2022-03-23 PlS Planned sale
Hoelscher Paul W.

EVP, CFO

Officer
26,090 -96.1%
110.00
US$2,870,002 		26,090 -96.1% 110.00 US$2,870,002
2022-03-11 2022-03-11 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
6,662 -1.2%
101.38
US$675,394 		6,662 -1.2% 101.38 US$675,394
2022-03-11 2022-03-11 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
18,338 -3.3%
100.77
US$1,847,920 		18,338 -3.3% 100.77 US$1,847,920
2022-03-04 2022-03-02 S Sale
2.2
DesJardin Michael A.

EVP, Technical Operations

Officer
13,518 -11.6%
97.42
US$1,316,924 		13,518 -11.6% 97.42 US$1,316,924
2022-03-04 2022-03-02 S Sale
2.2
DesJardin Michael A.

EVP, Technical Operations

Officer
21,482 -15.6%
97.05
US$2,084,828 		21,482 -15.6% 97.05 US$2,084,828
2022-03-01 2022-02-28 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
1,208 -0.2%
93.57
US$113,033 		1,208 -0.2% 93.57 US$113,033
2022-03-01 2022-02-28 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
2,900 -0.5%
92.50
US$268,250 		2,900 -0.5% 92.50 US$268,250
2022-03-01 2022-02-28 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
19,000 -3.4%
91.54
US$1,739,260 		19,000 -3.4% 91.54 US$1,739,260
2022-03-01 2022-02-28 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
26,892 -4.6%
90.41
US$2,431,306 		26,892 -4.6% 90.41 US$2,431,306
2022-03-01 2022-02-25 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
25,000 -4.1%
92.51
US$2,312,662 		25,000 -4.1% 92.51 US$2,312,662
2022-02-18 2022-02-18 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
1,313 -3.2%
94.82
US$124,499 		1,313 -3.2% 94.82 US$124,499
2022-02-11 2022-02-11 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
5,337 -0.9%
97.74
US$521,638 		5,337 -0.9% 97.74 US$521,638
2022-02-11 2022-02-11 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
19,663 -3.2%
97.32
US$1,913,603 		19,663 -3.2% 97.32 US$1,913,603
2022-01-31 2022-01-31 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
11,206 -1.9%
92.42
US$1,035,659 		11,206 -1.9% 92.42 US$1,035,659
2022-01-31 2022-01-31 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
74,253 -11.1%
91.94
US$6,826,821 		74,253 -11.1% 91.94 US$6,826,821
2022-01-31 2022-01-31 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
14,541 -2.1%
90.95
US$1,322,504 		14,541 -2.1% 90.95 US$1,322,504
2022-01-31 2022-01-28 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
25,000 -3.5%
90.00
US$2,250,000 		25,000 -3.5% 90.00 US$2,250,000
2022-01-14 2022-01-14 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
25,000 -3.6%
90.02
US$2,250,412 		25,000 -3.6% 90.02 US$2,250,412
2022-01-06 2022-01-06 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
349 -0.8%
100.23
US$34,980 		349 -0.8% 100.23 US$34,980
2022-01-06 2022-01-06 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
6,438 -13.5%
99.85
US$642,834 		6,438 -13.5% 99.85 US$642,834
2022-01-06 2022-01-06 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
700 -1.4%
98.33
US$68,831 		700 -1.4% 98.33 US$68,831
2022-01-06 2022-01-06 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
500 -1.0%
97.30
US$48,650 		500 -1.0% 97.30 US$48,650
2022-01-04 2021-12-31 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
7,522 -1.6%
108.55
US$816,513 		7,522 -1.6% 108.55 US$816,513
2022-01-04 2021-12-31 PlS Planned sale
Walbert Timothy P

Chairman, President and CEO

Executive Director
67,478 -12.7%
108.02
US$7,288,974 		67,478 -12.7% 108.02 US$7,288,974
2021-12-08 2021-12-07 PlS Planned sale
2.1
Pasternak Andy

EVP and Chief Business Officer

Officer
1,525 -6.5%
100.00
US$152,500 		1,525 -6.5% 100.00 US$152,500
2021-12-03 2021-12-01 S Sale
2.4
McHugh Miles W

Sr VP & Princ. Acctg Officer

Officer
79,484 -68.5%
106.62
US$8,474,584 		79,484 -68.5% 106.62 US$8,474,584
Explore more

More insider trading research around Horizon Therapeutics PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America